| MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity E Giovannetti, N Funel, GJ Peters, M Del Chiaro, LA Erozenci, E Vasile, ... Cancer research 70 (11), 4528-4538, 2010 | 534 | 2010 |
| Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by … G Masi, F Loupakis, L Pollina, E Vasile, S Cupini, S Ricci, IM Brunetti, ... Annals of surgery 249 (3), 420-425, 2009 | 322 | 2009 |
| Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin–treated advanced non–small cell lung cancer patients C Tibaldi, E Giovannetti, E Vasile, V Mey, AC Laan, S Nannizzi, ... Clinical cancer research 14 (6), 1797-1803, 2008 | 273 | 2008 |
| Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis G Masi, E Vasile, F Loupakis, S Cupini, L Fornaro, G Baldi, L Salvatore, ... Journal of the National Cancer Institute 103 (1), 21-30, 2011 | 234 | 2011 |
| PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC M Del Re, R Marconcini, G Pasquini, E Rofi, C Vivaldi, F Bloise, ... British journal of cancer 118 (6), 820-824, 2018 | 228 | 2018 |
| Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective … A Russo, M Russano, T Franchina, MR Migliorino, G Aprile, G Mansueto, ... Advances in therapy 37, 1145-1155, 2020 | 137 | 2020 |
| HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: implication for further clinical research F Pietrantonio, M Caporale, F Morano, M Scartozzi, A Gloghini, F De Vita, ... International journal of cancer 139 (12), 2859-2864, 2016 | 121 | 2016 |
| The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms S Caponi, N Funel, AE Frampton, F Mosca, L Santarpia, ... Annals of oncology 24 (3), 734-741, 2013 | 120 | 2013 |
| Natural history of non-small-cell lung cancer with bone metastases D Santini, S Barni, S Intagliata, A Falcone, F Ferraù, D Galetta, L Moscetti, ... Scientific reports 5 (1), 1-9, 2015 | 118 | 2015 |
| Role of CYB5A in pancreatic cancer prognosis and autophagy modulation E Giovannetti, Q Wang, A Avan, N Funel, T Lagerweij, JH Lee, V Caretti, ... Journal of the National Cancer Institute 106 (1), djt346, 2014 | 112 | 2014 |
| Anti-HER agents in gastric cancer: from bench to bedside L Fornaro, M Lucchesi, C Caparello, E Vasile, S Caponi, L Ginocchi, ... Nature reviews Gastroenterology & hepatology 8 (7), 369-383, 2011 | 112 | 2011 |
| FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer C Caparello, LL Meijer, I Garajova, A Falcone, TY Le Large, N Funel, ... World journal of gastroenterology 22 (31), 6987, 2016 | 97 | 2016 |
| Contribution of KRAS mutations and c. 2369C> T (p. T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA M Del Re, M Tiseo, P Bordi, A D'Incecco, A Camerini, I Petrini, M Lucchesi, ... Oncotarget 8 (8), 13611, 2017 | 95 | 2017 |
| Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center G Brandi, M Venturi, MA Pantaleo, G Ercolani, L Fornaro, N Silvestris, ... Digestive and Liver Disease 48 (3), 231-241, 2016 | 93 | 2016 |
| High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer E Giovannetti, A Van Der Velde, N Funel, E Vasile, V Perrone, LG Leon, ... PloS one 7 (11), e49145, 2012 | 93 | 2012 |
| Italian nivolumab expanded access program in nonsquamous non–small cell lung cancer patients: results in never-smokers and EGFR-mutant patients MC Garassino, AJ Gelibter, F Grossi, R Chiari, HS Parra, S Cascinu, ... Journal of Thoracic Oncology 13 (8), 1146-1155, 2018 | 86 | 2018 |
| Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer L Fornaro, S Cereda, G Aprile, S Di Girolamo, D Santini, N Silvestris, ... British journal of cancer 110 (9), 2165-2169, 2014 | 83 | 2014 |
| Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer M Del Re, C Vivaldi, E Rofi, E Vasile, M Miccoli, C Caparello, ... Scientific reports 7 (1), 7931, 2017 | 80 | 2017 |
| Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model C Tibaldi, E Vasile, I Bernardini, C Orlandini, M Andreuccetti, A Falcone Journal of cancer research and clinical oncology 134, 1143-1149, 2008 | 80 | 2008 |
| Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples E Giovannetti, AC Laan, E Vasile, C Tibaldi, S Nannizzi, S Ricciardi, ... Nucleosides, Nucleotides, and Nucleic Acids 27 (6-7), 720-725, 2008 | 68 | 2008 |
